Covered recipient · General Payments record
WILLIAM TETTELBACH
Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease
General Payments · PY2018–2024
$133,865.66
- Reported across 47 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Debt forgiveness | $100,400.00 | 1 |
| Consulting Fee | $5,000.00 | 1 |
| Food and Beverage | $1,551.26 | 14 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ConvaTec Inc. | $100,400.00 | 1 |
| BioWound Solutions, Inc. | $5,000.00 | 1 |
| MIMEDX Group, Inc. | $531.42 | 6 |
| ORGANOGENESIS INC. | $480.68 | 4 |
| Kerecis Limited | $285.26 | 1 |
| Smith & Nephew, Inc. | $253.90 | 3 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| BioWound Solutions, Inc. | $5,000.00 | 12/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1118399490 | CMS |
| Convatec Inc. | $100,400.00 | 06/27/2024 | Debt forgiveness | Undisputed | 01/23/2026 | 1151386002 | CMS |
| Kerecis Limited | $285.26 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120116476 | CMS |
| MIMEDX Group, Inc. | $38.97 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140270650 | CMS |
| MIMEDX Group, Inc. | $31.60 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140270652 | CMS |
| MIMEDX Group, Inc. | $130.91 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140270654 | CMS |
| MIMEDX Group, Inc. | $132.81 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140270656 | CMS |
| MIMEDX Group, Inc. | $126.74 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140270658 | CMS |
| MIMEDX Group, Inc. | $70.39 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140270660 | CMS |
| Organogenesis Inc. | $50.00 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145448805 | CMS |
| Organogenesis Inc. | $87.78 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145448807 | CMS |
| Organogenesis Inc. | $122.63 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145448809 | CMS |
| Organogenesis Inc. | $220.27 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145448811 | CMS |
| Smith+Nephew, Inc. | $75.72 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149496087 | CMS |
| Smith+Nephew, Inc. | $75.13 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149496085 | CMS |
| Smith+Nephew, Inc. | $103.05 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1149496089 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.